Vendors, Oversight and the Bottleneck

Part of Clinical Trial Assistant (CTA) Training: Vendor and Sponsor Coordination.

About 4 minutes. Free, in your language, no account needed.

Why this matters

Most trials run on vendors: central laboratories, imaging providers, couriers, interactive response systems, electronic data capture, translation services. The sponsor may delegate the work. It cannot delegate the responsibility.

ICH E6(R3) is clear that where a sponsor transfers trial-related duties to another party, the sponsor retains responsibility for the quality and integrity of the trial data. Oversight is therefore not optional courtesy; it is a duty with evidence attached.

What oversight looks like in practice

It is not a contract in a drawer. It is a documented record that somebody checked the vendor was doing what they agreed, and acted when they were not.

For your purposes that usually means: the transfer of responsibilities is documented and specific, there is an agreed performance expectation, someone reviews performance on a cycle, issues are logged and followed to closure, and the evidence of all of that is in the TMF.

The characteristic gap is a vendor performing well, nobody documenting the oversight, and the file containing no evidence that the sponsor was discharging its duty. A well-run vendor with no oversight record is still an oversight finding.

The bottleneck

Every study develops one vendor that becomes the constraint. Samples sit unanalysed, images are not read, translations do not return, and everything downstream waits.

Handle it in a specific order.

Quantify it. How many items, how long overdue, and what does the delay block. "The lab is slow" is not actionable; "forty-one samples from three sites, oldest eighteen days against a five-day turnaround, blocking two dose-escalation decisions" is.

Find the actual constraint. Vendors are rarely uniformly slow. It is usually one assay, one site's shipments, one courier lane, or one missing requisition field causing rejection at receipt. The constraint is often something the study is doing wrong at the sending end.

Escalate with the quantification. Vendor relationships are contractual, and contract holders act on numbers.

Track to closure. A vendor issue raised and not tracked recurs.

The line you should not cross

Vendor performance conversations belong to whoever owns the relationship. You provide the facts and the tracking. Committing to contractual remedies, agreeing scope changes, or negotiating fees is not yours, and doing it informally can undermine the study's position later.

A worked bottleneck

Sites are complaining that central laboratory results are late. The study's view is "the lab is slow".

Quantify it. Pull the numbers: 41 samples outstanding, from 3 of 11 sites, oldest 18 days against a contracted 5-day turnaround. Two of those results gate dose-escalation decisions for specific participants.

Find the constraint. It is not all 11 sites, which immediately rules out a general capacity problem. Looking at the three: all three ship on the same courier lane, and all three have had samples rejected at receipt for an incomplete requisition field. The samples were not slow; they were rejected and re-drawn.

So the constraint is at the sending end, which is the most common answer and the least expected one. The fix is a requisition correction and site retraining, not a vendor escalation.

Escalate anyway, with the finding. The vendor should be telling the study about rejections faster than 18 days, and that is a legitimate oversight point.

Oversight evidence, concretely

For each vendor the file should let someone answer: what were they contracted to do, what were they expected to achieve, who checked, how often, what did they find, and what happened about it.

If the honest answer to "who checked" is that nobody did because performance seemed fine, that is the finding, and it exists independently of whether the vendor did a good job.

The cheapest way to have this evidence is a short quarterly note per vendor: metrics reviewed, issues open, actions. Ten minutes each, and it converts an oversight duty from an assertion into a record.

Key takeaways